natgillin/translations-raw huggingface dataset:
• A visually engaging instruction guide demonstrating step-by-step procedure for the use of the AI will be developed and distributed to nurses and HCPs to facilitate training of patients and staff in the prescriber´s office or during a homecare program 
• oblikovana bodo grafično učinkovita navodila s podrobno prikazanim postopkom uporabe avtoinjektorja, ki bodo razdeljena medicinskim sestram in zdravstvenim delavcem za lažje poučevanje bolnikov in osebja v ambulanti predpisovalca ali v programu zdravstvene oskrbe na domu;
Slowly release the plunger and allow the needle guard to automatically cover the exposed needle. 
Počasi spustite bat in pustite, da zapiralo igle samodejno pokrije izpostavljeno iglo.
Children and adults taking Erelzi may have an increased risk of developing lymphoma or another cancer. 
Pri otrocih in odraslih, ki prejemajo zdravilo Erelzi, je morda tveganje za nastanek limfoma ali druge oblike raka večje.
The syringe cannot be re-used. 
Injekcijske brizge ne smete ponovno uporabiti.
If any serious allergic or anaphylactic reaction occurs, Erelzi therapy should be discontinued immediately and appropriate therapy initiated. 
Če se pojavi kakršna koli resna alergijska ali anafilaktična reakcija, je treba zdravljenje z zdravilom Erelzi takoj prekiniti in uvesti ustrezno zdravljenje.
Erelzi is not indicated for use in children and adolescents who weigh less than 62.5 kg. 
Zdravilo Erelzi ni indicirano za uporabo pri otrocih in mladostnikih, ki tehtajo manj kot 62,5 kg.
There have been post-marketing reports of interstitial lung disease (including pneumonitis and pulmonary fibrosis), some of which had fatal outcomes. 
V obdobju trženja so poročali o intersticijski bolezni pljuč (vključno s pnevmonitisom in pljučno fibrozo), nekateri od teh primerov so bili tudi smrtni.
For psoriatic arthritis patients with multiple joint involvement, Erelzi can improve your ability to do normal daily activities. 
Pri bolnikih s psoriatičnim artritisom in prizadetostjo več sklepov lahko zdravilo Erelzi izboljša sposobnost opravljanja običajnih vsakdanjih dejavnosti.
The following list of adverse reactions is based on experience from clinical trials in adults and on post-marketing experience. 
Preglednica neželenih učinkov Spodnji seznam neželenih učinkov temelji na izkušnjah iz kliničnih preskušanj pri odraslih ter na izkušnjah iz obdobja trženja.
If an alternate dose is required, other etanercept products offering such an option should be used. 
Če je potreben drugačen odmerek, je treba uporabiti druga zdravila z etanerceptom, ki to omogočajo.
Be careful not to touch the needle guard wings before use. 
Pazite, da se pred odmerjanjem ne boste dotikali kril zapirala igle.
Erelzi is not recommended for the treatment of Wegener's granulomatosis. 
Zdravila Erelzi ni priporočljivo uporabljati za zdravljenje Wegenerjeve granulomatoze.
If Erelzi has no effect on the child's condition after 12 weeks, your doctor may tell you to stop using this medicine. 
Če zdravilo Erelzi po 12 tednih nima nobenega učinka na otrokovo stanje, vam bo zdravnik morda naročil, da prenehajte uporabljati to zdravilo.
Keep the plunger pressed fully down while you hold the syringe in place for 5 seconds. 
Bat držite pritisnjen do konca in brizgo zadržite v istem položaju 5 sekund.
In patients who develop HBV infection, Erelzi should be stopped and effective anti-viral therapy with appropriate supportive treatment should be initiated. 
Pri bolnikih, pri katerih se razvije okužba s HBV, je treba zdravljenje z zdravilom Erelzi prekiniti in uvesti učinkovito protivirusno ter ustrezno podporno zdravljenje.
If Erelzi has no effect on your condition after 12 weeks, your doctor may tell you to stop using this medicine. 
Če zdravilo Erelzi po 12 tednih nima nobenega učinka na vašo bolezen, vam zdravnik lahko naroči, da to zdravilo nehate uporabljati.
• Reminder that Erelzi should not be used in children and adolescents weighing less than 62.5 kg. 
• opozorilo, da se zdravila Erelzi ne sme uporabljati pri otrocih in mladostnikih, ki tehtajo manj kot 62,5 kg;
In a 48-week study in 211 children aged 4 to 17 years with paediatric plaque psoriasis, the adverse events reported were similar to those seen in previous studies in adults with plaque psoriasis. 
V 48-tedenski študiji pri 211 otrocih, starih 4 do 17 let, z otroško psoriazo v plakih so bili poročani neželeni učinki podobni tistim, ki so jih opažali v predhodnih študijah pri odraslih s psoriazo v plakih.
You can press a cotton ball or gauze over the injection site and hold it for 10 seconds. 
Na to mesto lahko pritisnete kosem vate ali zloženec iz gaze in ga držite 10 sekund.
Consequently, Erelzi should not be used in patients for the treatment of alcoholic hepatitis. 
Zato zdravila Erelzi ne smemo uporabljati pri bolnikih za zdravljenje alkoholnega hepatitisa.
• Request to ask the doctor to record test, date and results of last TB screening on the alert card 
• napotek bolniku, naj zdravnika prosi, da na opozorilno kartico za bolnika vpiše datum in rezultate zadnjega presejalnega testa za TB;
If active tuberculosis is diagnosed, Erelzi therapy must not be initiated. 
Če je postavljena diagnoza aktivne tuberkuloze, se zdravljenja z zdravilom Erelzi ne sme uvesti.
If it has expired, return the entire pack to the pharmacy. 
Če zdravilu poteče rok uporabnosti, celotno pakiranje vrnite v lekarno.
Treatment of adults with severe non-radiographic axial spondyloarthritis with objective signs of inflammation as indicated by elevated C-reactive protein (CRP) and/or magnetic resonance imaging (MRI) evidence, who have had an inadequate response to non-steroidal anti-inflammatory drugs (NSAIDs). 
Zdravljenje odraslih s hudim radiografsko nezaznavnim aksialnim spondilartritisom in objektivnimi znaki vnetja (na katerega kažejo povišana vrednost C-reaktivnega proteina (CRP) in/ali dokazi magnetnoresonančnega slikanja (MRI)), ki imajo nezadostni odziv na nesteroidna protivnetna zdravila
Placebo N = 106 to 109* 
Placebo n = 106 do 109*
A placebo-controlled trial, in which 89 adult patients were treated with etanercept in addition to standard therapy (including cyclophosphamide or methotrexate, and glucocorticoids) for a median duration of 25 months, has not shown etanercept to be an effective treatment for Wegener's granulomatosis. 
Wegenerjeva granulomatoza S placebom nadzorovano preskušanje, v katerem je 89 odraslih bolnikov poleg standardnega zdravljenja (vključno s ciklofosfamidom ali metotreksatom in glukokortikoidi) jemalo etanercept z medianim časom zdravljenja 25 mesecev, ni pokazalo učinkovitosti etanercepta za zdravljenje Wegenerjeve granulomatoze.
• Not known (frequency cannot be estimated from the available data): Merkel cell carcinoma (a type of skin cancer); excessive activation of white blood cells associated with inflammation (macrophage activation syndrome); recurrence of hepatitis B (a liver infection); worsening of a condition called dermatomyositis (muscle inflammation and weakness with an accompanying skin rash). 
• Neznana (pogostnosti iz razpoložljivih podatkov ni mogoče oceniti): karcinom Merklovih celic (vrsta kožnega raka); čezmerna aktivacija belih krvničk, povezanih z vnetjem (sindrom aktivacije makrofagov); ponovitev hepatitisa B (vnetje jeter); poslabšanje stanja, imenovanega dermatomiozitis (vnetje mišic in mišična oslabelost, ki ju spremlja kožni izpuščaj).
• Free lines to record brand name and batch number 
• prazne črte za zapis trgovskega imena in številke serije.
The incidence of non-cutaneous malignancies of various types was significantly higher in patients treated with etanercept than in the control group. 
Pojavnost nekožnih malignih obolenj različnih tipov je bila pomembno večja pri bolnikih, zdravljenih z etanerceptom, kot pri tistih v kontrolni skupini.
ASAS 70 2 weeks 
ASAS 70 2 tedna
ASAS 50 2 weeks 
ASAS 50 2 tedna
Within the system organ classes, adverse reactions are listed under headings of frequency (number of patients expected to experience the reaction), using the following categories: very common (≥ 1/10); 
Znotraj organskih sistemov so neželeni učinki navedeni po pogostnosti (število bolnikov, pri katerih se pričakuje pojav učinka), z uporabo naslednjih kategorij: zelo pogosti (≥ 1/10); pogosti (≥ 1/100 do
In a group of 2,711 plaque psoriasis patients treated with etanercept in double-blind and open-label studies of up to 2.5 years, 30 malignancies and 43 non-melanoma skin cancers were reported. 
V skupini 2.711 bolnikov s psoriazo v plakih, zdravljenih z etanerceptom v dvojno slepih in odprtih študijah, ki so trajale do 2,5 leta, so poročali o 30 malignomih in 43 primerih nemelanomskega kožnega raka.
Autoantibody formation Treatment with Erelzi may result in the formation of autoimmune antibodies (see section 4.8). 
Tvorba avtoprotiteles Zdravljenje z zdravilom Erelzi lahko sproži nastajanje avtoimunskih protiteles (glejte poglavje 4.8).
Erelzi is a biosimilar medicinal product. 
Zdravilo Erelzi je podobno biološko zdravilo.
• Wegener's granulomatosis: Erelzi is not recommended for the treatment of Wegener's granulomatosis, a rare inflammatory disease. 
• Wegenerjeva granulomatoza: Zdravilo Erelzi ni priporočljivo za zdravljenje redke vnetne bolezni Wegenerjeve granulomatoze.
If re-treatment with etanercept is indicated, the same guidance on treatment duration should be followed. 
Če je indicirano ponovno zdravljenje z etanerceptom, se moramo ravnati po istih smernicah glede trajanja zdravljenja.
Patients treated with Erelzi should be given the Patient Alert Card. 
Bolniki, ki se zdravijo z zdravilom Erelzi, naj prejmejo opozorilno kartico za bolnika.
Erelzi may be stored at temperatures up to a maximum of 25 °C for a single period of up to four weeks; after which, it should not be refrigerated again. 
Zdravilo Erelzi se lahko shranjuje pri temperaturi do največ 25 °C za enkratno obdobje do štirih tednov, po katerem se ga ne sme več ohladiti.
After a single subcutaneous dose of 25 mg etanercept, the average maximum serum concentration observed in healthy volunteers was 1.65 ± 0.66 µg/ml, and the area under the curve was 235 ± 96.6 µg•hr/ml. 
Po enkratnem subkutanem odmerku 25 mg etanercepta je bila povprečna največja koncentracija zdravila v serumu pri zdravih prostovoljcih 1,65 ± 0,66 μg/ml, površina pod krivuljo pa 235 ± 96,6 μg•h/ml.
• Vaccinations: If possible, children should be up to date with all vaccinations before using Erelzi. 
• Cepljenja: Najbolje je, da otrok pred začetkom zdravljenja z zdravilom Erelzi opravi vsa predvidena cepljenja.
The use of Erelzi is not expected to affect the ability to drive or use machines. 
Ni pričakovati, da bi zdravilo Erelzi vplivalo na sposobnost upravljanja vozil in strojev.
You must keep holding the pen firmly against your skin until you see a green indicator fill the window and stop moving. 
Injekcijski peresnik še naprej močno pritiskajte v kožo, dokler zeleni indikator povsem ne zapolni okenca in se neha premikati.
The majority of the reports with a fatal outcome were in patients with Pneumocystis pneumonia, unspecified systemic fungal infections, and aspergillosis (see section 4.4). 
Večina poročil o smrtnih izidih je opisovala bolnike s pljučnico, ki jo je povzročila glivica Pneumocystis, z nespecifičnimi sistemskimi glivičnimi okužbami in aspergilozo (glejte poglavje 4.4).
Assessment in Ankylosing Spondylitis (ASAS) domains (patient global assessments, back pain, BASFI, and inflammation) and absence of deterioration in the remaining domain. 
Ocenjevanje pri ankilozirajočem spondilitisu (ASAS - Assessment in Ankylosing Spondylitis) (bolnikova splošna ocena, bolečina v hrbtenici, BASFI in vnetje) ter odsotnost poslabšanja pri četrti domeni.
To help you remember, it may be helpful to write in a diary which day(s) of the week Erelzi should be used. 
Da si boste lažje zapomnili, vam bo morda pomagalo, če si v koledarju zabeležite dan (dneve) v tednu,
The injection site is the place on the body where you are going to use the pre-filled syringe. 
Mesto injiciranja je predel telesa, na katerem boste uporabili napolnjeno injekcijsko brizgo.
• Do not inject into areas where the skin is tender, bruised, red, scaly or hard. 
• Zdravila ne injicirajte v predele, kjer je koža bolj občutljiva, podpluta, rdeča, luskasta ali trda.
Abbreviation: sPGA-static Physician Global Assessment a. p < 0.0001 compared with placebo 
Okrajšava: sPGA-statična zdravnikova splošna ocena a. p < 0,0001 v primerjavi s placebom
If you stop using Erelzi 
Če ste prenehali uporabljati zdravilo Erelzi
Of the rheumatoid arthritis patients evaluated for antinuclear antibodies (ANA), the percentage of patients who developed new positive ANA (≥ 1:40) was higher in patients treated with etanercept (11%) than in placebo-treated patients (5%). 
Pri bolnikih z revmatoidnim artritisom, ki so jih testirali na antinuklearna protitelesa (ANA - antinuclear antibodies), je bil odstotek tistih, ki so razvili nova pozitivna ANA (≥ 1:40), večji pri bolnikih, ki so prejemali etanercept (11 %), kot pri tistih, ki so prejemali placebo (5 %).
Store in the refrigerator between 2 °C to 8 °C. 
Shranjujte jo v hladilniku pri temperaturi od 2 °C do 8 °C.
TNF-antagonists, such as etanercept, affect the immune system and their use may affect the body's defences against infection and cancer. 
Zaviralci TNF, kot je etanercept, vplivajo na imunski sistem in lahko zmanjšajo sposobnost organizma za obrambo pred okužbami in rakom.
Physicians should use caution when using Erelzi in patients who also have moderate to severe alcoholic hepatitis. 
Zdravniki naj bodo pazljivi, kadar uporabljajo zdravilo Erelzi pri bolnikih, ki imajo tudi zmeren do hud alkoholni hepatitis.
The 1st click indicates that the injection has started. 
1. klik pomeni, da se je injiciranje začelo.
• Request to show the Patient Alert Card to any treating doctor 
• napotek, da je treba opozorilno kartico za bolnika pokazati vsem zdravnikom, ki zdravijo bolnika;
The needle guard will help to prevent needle stick injuries to anyone who handles the pre-filled syringe. 
Zapiralo igle pomaga preprečiti poškodbe zaradi vbodov z iglo za vsakogar, ki rokuje z napolnjeno injekcijsko brizgo.
• The green indicator shows the progress of the injection. 
• Zeleni indikator kaže potek injiciranja.
Several adverse events were reported more commonly in 69 juvenile idiopathic arthritis patients receiving 3 months of etanercept compared to the 349 adult rheumatoid arthritis patients. 
Nekateri neželeni učinki so bili pogosteje opaženi pri 69 bolnikih z juvenilnim idiopatskim artritisom, ki so etanercept prejemali 3 mesece, v primerjavi s 349 odraslimi bolniki z revmatoidnim artritisom.
Although no clinical trials have been performed evaluating etanercept therapy in patients with multiple sclerosis, clinical trials of other TNF antagonists in patients with multiple sclerosis have shown increases in disease activity. 
Čeprav niso opravili kliničnih preskušanj za ovrednotenje zdravljenja z etanerceptom pri bolnikih z multiplo sklerozo, so klinična preskušanja drugih zaviralcev TNF pri teh bolnikih pokazala zvečano aktivnost bolezni.
However, any of the above symptoms may indicate an allergic reaction to Erelzi, so you should seek immediate medical attention. 
Resne alergijske reakcije so redke, vendar pa lahko katerikoli od zgoraj navedenih simptomov kaže na pojav alergijske reakcije na zdravilo Erelzi, zato morate nemudoma poiskati zdravniško pomoč.
In another observational multi-country registry study comparing the risk of adverse pregnancy outcomes in women exposed to etanercept during the first 90 days of pregnancy (n = 425) to those exposed to nonbiologic drugs (n = 3497), there was no observed increased risk of major birth defects (crude odds ratio [OR] = 1.22, 95% CI: 0.79 - 1.90; adjusted OR = 0.96, 95% CI: 0.58 - 1.60 after adjusting for country, maternal disease, parity, maternal age and smoking in early pregnancy). 
V drugi opazovalni registrski študiji, ki so jo izvajali v več državah in v kateri so primerjali tveganje za neželene izide nosečnosti pri ženskah, izpostavljenih etanerceptu v prvih 90 dneh nosečnosti (n = 425), in pri ženskah, ki so bile izpostavljene nebiološkim zdravilom (n = 3.497), niso opazili povečanega tveganja za resne prirojene napake (grobo razmerje obetov [OR - Odds Ratio] = 1,22, 95 % IZ: 0,79-1,90; prilagojeno OR = 0,96, 95 % IZ: 0,58-1,60 po prilagoditvi glede na državo, materino bolezen, pariteto, starost matere in kajenje v zgodnji nosečnosti).
You have been prescribed a 50 mg strength of Erelzi. 
Predpisana vam je bila jakost 50 mg zdravila Erelzi.
The pre-filled syringe has a needle guard that will be activated to cover the needle after the injection is finished. 
Napolnjena injekcijska brizga ima zapiralo igle, ki se bo aktiviralo in po koncu injiciranja iglo prekrilo.
Choose your injection site: 
Izberite mesto injiciranja:
If you have any questions, please talk to a doctor, nurse or pharmacist who is familiar with Erelzi. 
Če imate kakršnakoli vprašanja, se posvetujte z zdravnikom, medicinsko sestro ali farmacevtom, ki zdravilo Erelzi pozna.
Patients weighing less than 62.5 kg should be accurately dosed on a mg/kg basis using the powder and solvent for solution for injection presentations or the powder for solution for injection presentations (see below for dosing for specific indications). 
Bolnikom, ki tehtajo manj kot 62,5 kg, je treba odmerek natančno izračunati na podlagi mg/kg in uporabiti zdravilo v obliki praška in vehikla za raztopino za injiciranje ali praška za raztopino za injiciranje (za odmerjanje pri specifičnih indikacijah glejte nadaljevanje).
• Hepatitis C: Tell your doctor if you or the child have hepatitis C. Your doctor may wish to monitor the treatment with Erelzi in case the infection worsens. 
• Hepatitis C: Povejte zdravniku, če imate vi ali vaš otrok hepatitis C. Zdravnik bo morda želel spremljati zdravljenje z zdravilom Erelzi za primer, če bi se okužba poslabšala.
• Polyarthritis (rheumatoid factor positive or negative) and extended oligoarthritis in patients from the age of 2 years and weighing 62.5 kg or more. 
• poliartritisa (pozitivnega ali negativnega za revmatoidni faktor) in razširjenega oligoartritisa pri bolnikih, starejših od 2 let, ki tehtajo 62,5 kg ali več.
• Infections/surgery: If you or the child develop a new infection, or are about to have any major surgery, your doctor may wish to monitor the treatment with Erelzi. 
• Okužbe/operacije: Če se pri vas ali otroku pojavi nova okužba ali če je pri vas ali otroku predvidena kakršnakoli večja operacija, bo zdravnik morda želel spremljati zdravljenje z zdravilom Erelzi.
Hold the syringe finger flange as shown. 
Injekcijsko brizgo primite za držalo za prste, kot kaže slika.
It is recommended that the conduct of these tests should be recorded in the Patient's Alert Card. Prescribers are reminded of the risk of false negative tuberculin skin test results, especially in patients who are severely ill or immunocompromised. 
Zdravnike predpisovalce opominjamo na nevarnost lažno negativnih rezultatov tuberkulinskega kožnega testa, še zlasti pri bolnikih, ki so hudo bolni ali imunokompromitirani.
Allergic reactions; fever; rash; itching; antibodies directed against normal tissue (autoantibody formation). 
alergijske reakcije; vročina; izpuščaj; srbenje; protitelesa proti normalnemu tkivu (nastanek avtoprotiteles).
The long-term safety and effectiveness of etanercept 0.8 mg/kg (up to 50 mg) once weekly was assessed in an open-label extension study of 181 paediatric subjects with plaque psoriasis for up to 2 years beyond the 48 week study discussed above. 
Dolgoročna varnost in učinkovitost etanercepta v odmerkih 0,8 mg/kg (do 50 mg) enkrat na teden je bila ovrednotena v odprti podaljšani študiji, v kateri je sodelovalo 181 otrok s psoriazo v plakih, ki so se zdravili do 2 leti po zaključku 48-tedenske študije, navedene zgoraj.
Erelzi is administered by an injection under the skin (by subcutaneous injection). 
Zdravilo Erelzi se injicira pod kožo (subkutano injiciranje).
Appropriate screening tests, i.e., tuberculin skin test and chest X-ray, should be performed in all patients (local recommendations may apply). 
tj. tuberkulinski kožni test in rentgensko slikanje prsnega koša (morda obstajajo nacionalna priporočila glede teh preiskav).
One rheumatoid arthritis patient mistakenly self-administered 62 mg etanercept subcutaneously twice weekly for 3 weeks without experiencing undesirable effects. 
En bolnik z revmatoidnim artritisom si je pomotoma subkutano injiciral 62 mg etanercepta 2-krat tedensko 3 tedne, pri tem pa ni prišlo do pojava neželenih učinkov.
Erelzi is also indicated in the treatment of severe, active and progressive rheumatoid arthritis in adults not previously treated with methotrexate. 
Zdravilo Erelzi je indicirano tudi za zdravljenje hudega, aktivnega in napredujočega revmatoidnega artritisa pri odraslih, ki še niso dobivali metotreksata.
Such patients should be investigated urgently, including full blood count; if blood dyscrasias are confirmed, Erelzi should be discontinued. 
Take bolnike je treba nemudoma pregledati, vključno s pregledom celotne krvne slike, in v primeru diagnosticiranja krvne diskrazije prekiniti zdravljenje z zdravilom Erelzi.
• Brief introduction to the aim of the Patient Alert Card 
• kratka predstavitev namena opozorilne kartice za bolnika;
At week 104, 8 subjects had progressed to a score of bilateral Grade 2 on spinal X-ray according to the modified New York Radiological Grade, indicative of axial spondyloarthropathy. 
Po 104 tednih je 8 preskušancev napredovalo do stopnje 2 obojestransko, merjene z rentgenskim slikanjem hrbtenice, kar po spremenjenih newyorških merilih za radiološko oceno kaže na aksialno spondiloartropatijo.
Carcinogenicity studies, and standard assessments of fertility and postnatal toxicity, were not performed with etanercept due to the development of neutralising antibodies in rodents. 
Študij kancerogenosti in standardnih raziskav plodnosti in postnatalne toksičnosti zaradi tvorbe nevtralizirajočih protiteles pri glodalcih niso opravili.
Your doctor will decide how long you should use Erelzi and whether retreatment is needed based on your response. 
Zdravnik bo na podlagi vašega odziva na zdravilo določil, koliko časa morate uporabljati zdravilo Erelzi in ali je potrebno ponovno zdravljenje.
What you additionally need for your injection: 
Dodatni pripomočki, ki jih potrebujete pri injiciranju:
These instructions are to help you to inject correctly using the Erelzi SensoReady pen. 
Ta navodila vam bodo pomagala, da boste pri injiciranju zdravila Erelzi pravilno uporabljali injekcijski peresnik SensoReady.
Treatment of active and progressive psoriatic arthritis in adults when the response to previous disease-modifying antirheumatic drug therapy has been inadequate. 
Zdravljenje aktivnega in progresivnega psoriatičnega artritisa pri odraslih, če je bil odziv na predhodnje zdravljenje z imunomodulirajočimi antirevmatičnimi zdravili nezadosten.
Study 2 evaluated 652 patients with chronic plaque psoriasis using the same inclusion criteria as study 1 with the addition of a minimum psoriasis area and severity index (PASI) of 10 at screening. 
Študija 2 je ocenila 652 bolnikov s kronično psoriazo v plakih in je imela enaka vključitvena merila kot študija 1, le da so imeli bolniki ob presejanju še minimalen predel s psoriazo in vrednost indeksa PASI vsaj 10.
Erelzi should be discarded if not used within four weeks after removal from the refrigerator. 
Zdravilo Erelzi zavrzite, če ga ne porabite v štirih tednih po odvzemu iz hladilnika.
If you have psoriasis, you should NOT inject directly into any raised, thick, red, or scaly skin patches or lesions (“psoriasis skin lesions”). 
Če imate luskavico, si NE injicirajte v izbočene, odebeljene, pordele ali luskave dele kože ali v lezije ("psoriatične kožne lezije").
INSTRUCTIONS ON USE ‘QR code to be included' + www.erelzi.eu 
‘Vključiti kodo QR' + www.erelzi.eu
• Never try to re-use your pen. 
• Že uporabljenega injekcijskega peresnika nikoli ne poskušajte ponovno uporabiti.